Results 241 to 250 of about 136,170 (301)
The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension. [PDF]
DrugsMasi S +7 more
europepmc +1 more source
Protective Effects of Selective β-Adrenoceptor Blockade on Renal Pathophysiology in a Catecholamine Storm of Rat. [PDF]
Int J Mol SciChen BH +6 more
europepmc +1 more source
Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study. [PDF]
BMJ Open OphthalmolAbboud I +7 more
europepmc +1 more source
Severe Arrhythmia Complicating Takotsubo Cardiomyopathy Revealing an Underlying Pheochromocytoma: A Case Report. [PDF]
CureusTabat M, El Jaouhari Z, Drighil A.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Beta-adrenergic blockers in pregnancy
American Heart Journal, 1988The therapeutic indications for &adrenergic blocking drugs are varied. These drugs have proven efficacy in the treatment of hypertension, arrhythmias, hyperthyroidism, atherosclerotic heart disease, essential tremor, migraine headache, and glaucoma.’ Many of these conditions will manifest themselves during the reproductive years of the female patient ...
W H, Frishman, M, Chesner
openaire +2 more sources
Hypersomnolence with Beta-Adrenergic Blockers
Chest, 1987An elderly, mildly demented, hypertensive male patient developed hypersomnolence on administration of propranolol for treatment of hypertension; no other cause for hypersomnolence was detected. Upon replacement of propranolol with atenolol, he felt better but continued to be quite somnolent.
J, Thachil, J R, Zeller, M S, Kochar
openaire +2 more sources
A Toxicological Review of Beta-Adrenergic Blockers
Toxicological Sciences, 1986The use of various beta-adrenergic blockers has become extensive as they have been found to be efficacious in the treatment of a number of cardiovascular problems including cardiac arrhythmias, angina pectoris, and hypertension. The widespread and chronic use of these drugs has generated a concern for their potential chronic toxicity.
C D, Jackson, L, Fishbein
openaire +2 more sources
Postgraduate Medicine, 1984
The six currently available beta-adrenergic blocking agents have significant and clinically important differences in their potency, selectivity, partial agonist effect, lipid solubility, and cost. These differences account for many of the observed variations in drug action and dosage scheduling as well as for some of the side effects.
R E, Vlietstra, M D, McGoon
openaire +2 more sources
The six currently available beta-adrenergic blocking agents have significant and clinically important differences in their potency, selectivity, partial agonist effect, lipid solubility, and cost. These differences account for many of the observed variations in drug action and dosage scheduling as well as for some of the side effects.
R E, Vlietstra, M D, McGoon
openaire +2 more sources
Medical Clinics of North America, 1988
alpha-Adrenergic blockers are important drugs in the treatment of hypertension and other cardiovascular and noncardiovascular disorders. The ability to selectively block alpha-receptor subtypes provides a greater margin of safety and efficacy for these drugs.
William H. Frishman, Shlomo Charlap
openaire +1 more source
alpha-Adrenergic blockers are important drugs in the treatment of hypertension and other cardiovascular and noncardiovascular disorders. The ability to selectively block alpha-receptor subtypes provides a greater margin of safety and efficacy for these drugs.
William H. Frishman, Shlomo Charlap
openaire +1 more source